Last reviewed · How we verify
placebo (XLJDOD mimetic agent)
This is a placebo control agent designed to mimic the properties of XLJDOD for use in clinical trials.
At a glance
| Generic name | placebo (XLJDOD mimetic agent) |
|---|---|
| Sponsor | Jiangsu Famous Medical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo mimetic agent, this drug is formulated to resemble XLJDOD in appearance, taste, and administration route to maintain blinding in phase 3 clinical trials. It contains no active pharmaceutical ingredient and serves as a control comparator to assess the true efficacy and safety of the active investigational agent.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |